The mission of the Department of Cancer Biology is to build bridges and teams to drive the best ideas in basic and translational cancer biology and developmental therapeutics to achieve breakthrough advances in the prevention, treatment and cure of cancer.
The department faculty are international leaders in brain, colorectal and prostate cancers, leukemia and myeloma, as well as cancer stem cells, mechanisms of DNA damage and repair, and fundamental molecular and cellular processes that impact microbial infections and cancer. Identifying the molecular mechanisms involved in the development and progression of human cancers as well as in normal cellular regulatory processes is our goal, enabling us to achieve our long-term objective of rapidly translating research into strategies that improve patient outcomes.
The Abhishek Chakraborty lab studies oxygen loss and processes oxygen-deprived cancer cells employ for survival.
Learn MoreThe Candece Gladson lab investigates blocking angiogenesis and key molecules that promote survival in malignant glioma tumors.
Learn MoreThe Lang lab investigates breast cancer, studying liquid biopsies, tumor biology and inflammatory breast cancer.
Learn MoreJennifer Yu, MD, PhD, who was recently appointed as a council member for ASCI, shares insights on the importance of tackling disease from both the bedside and the bench.
Joshua Arbesman, MD, answers our biggest questions about skin cancer, including what it is, how to prevent melanoma and whether melanoma is hereditary.
PALA’s fifty-year journey to a promising multi-cancer treatment highlights the importance of basic science in research.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Cancer Biology.
View Careers